Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders

doi:10.4252/wjsc.v11.i2.55

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13570)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

713

WORD

340

HTML

8536

Figures (1-2)

551

Tables (1-2)

320

Sum=10460

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

470

Download

713

Sum=1183

Publishing Process of This Article

Item

Count

Browse

889

Download

1038

Sum=1927

Feb 26, 2019 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Feb 26, 2019; 11(2): 55-72
Published online Feb 26, 2019. doi: 10.4252/wjsc.v11.i2.55

Table 2 Autoimmune diseases, autism spectrum disorders, and mesenchymal stem cells

Autoimmune diseases	ASD	MSCs
Autoimmune thyroiditis	+	Pre-clinical experiment
Rheumatoid arthritis	+	Pre-clinical experiment; Clinical trials on-going
GVHD	-	Pre-clinical experiment; Clinical trials
MS	-	Pre-clinical experiment; Clinical trials on-going
Type 1 diabetes	+	Pre-clinical experiment; Clinical trials on-going

ASD: Autism spectrum disorders; MSCs: Mesenchymal stem cells; GVHD: graft-versus-host-disease; MS: Multiple sclerosis; +: An association between ASD and a family history of autoimmune diseases; -: No or lack of evidence of correlation between autoimmune diseases and ASD.

Citation: Liu Q, Chen MX, Sun L, Wallis CU, Zhou JS, Ao LJ, Li Q, Sham PC. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders. World J Stem Cells 2019; 11(2): 55-72
URL: https://www.wjgnet.com/1948-0210/full/v11/i2/55.htm
DOI: https://dx.doi.org/10.4252/wjsc.v11.i2.55